Skip to main content

Baxter International income statement

  • BAX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$25.81+0.27%Close 13 Nov 2026 · Market value $13.30B

Baxter International reported revenue of $11.2 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 5.7% from fiscal 2024. Net income was −$957 million and diluted earnings per share −$1.87.

From Baxter International's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Baxter International income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$11.26B$12.35B$12.56B$12.84B$13.89B$13.94B$9.41B$10.72B$9.97B$10.16B$10.58B$11.10B$11.36B$11.67B$12.15B$10.06B$10.36B$10.64B$11.24B$11.61B
Revenue growth—+9.6%+1.7%+2.2%+8.2%+0.3%−32.5%+13.9%−7.0%+2.0%+4.1%+4.9%+2.4%+2.7%+4.1%−17.2%+3.0%+2.7%+5.7%—
Net interest income——————−$128.0M−$145.0M−$126.0M−$66.00M−$55.00M−$45.00M−$71.00M−$134.0M−$193.0M−$395.0M−$439.0M−$341.0M−$238.0M−$249.0M
Cost of revenue$5.74B$6.22B$6.04B$6.88B$6.85B$6.80B$5.25B$6.14B$5.82B$6.05B$6.11B$6.34B$6.60B$7.09B$7.43B$6.51B$6.21B$6.65B$7.87B$8.12B
Gross profit$5.52B$6.13B$6.53B$5.96B$7.05B$7.13B$4.16B$4.58B$4.15B$4.12B$4.47B$4.76B$4.76B$4.59B$4.72B$3.55B$4.15B$3.98B$3.38B$3.49B
Gross margin49.0%49.6%51.9%46.4%50.7%51.2%44.2%42.7%41.6%40.5%42.3%42.9%41.9%39.3%38.9%35.3%40.1%37.5%30.1%30.1%
Research and development$760.0M$868.0M$917.0M$915.0M$946.0M$1.08B$582.0M$610.0M$603.0M$646.0M$615.0M$654.0M$595.0M$521.0M$531.0M$450.0M$518.0M$590.0M$518.0M$519.0M
Selling, general and administrative$2.52B$2.70B$2.73B$2.91B$3.15B$3.28B$3.08B$3.31B$3.09B$2.73B$2.63B$2.62B$2.54B$2.47B$2.85B$3.10B$2.95B$2.97B$2.89B$2.95B
Operating expenses—$3.52B$3.67B—$4.14B—$3.67B$3.92B$3.70B$3.37B$3.19B——$2.97B$3.37B—$3.44B———
Operating income—$2.61B$2.85B$2.00B$2.90B$2.95B$496.0M$656.0M$449.0M$745.0M$1.29B$1.58B$1.77B$1.62B$1.35B−$2.85B$707.0M$14.00M−$308.0M−$221.0M
Operating margin—21.1%22.7%15.6%20.9%21.2%5.3%6.1%4.5%7.3%12.2%14.3%15.6%13.8%11.1%−28.3%6.8%0.1%−2.7%−1.9%
Interest expense—$148.0M$117.0M$115.0M$92.00M$113.0M$155.0M$167.0M$146.0M$89.00M$85.00M$93.00M$111.0M$153.0M$207.0M$413.0M$508.0M$408.0M$290.0M—
Income before tax$2.13B$2.46B$2.73B$1.89B$2.81B$2.84B$375.0M$490.0M$428.0M$4.95B$1.10B$1.62B$970.0M$1.29B$1.12B−$3.25B$242.0M−$289.0M−$505.0M−$187.0M
Income tax expense$407.0M$437.0M$519.0M$463.0M$553.0M$555.0M$60.00M$33.00M$35.00M−$12.00M$491.0M$65.00M−$41.00M$182.0M$83.00M−$135.0M$61.00M$37.00M$395.0M$432.0M
Effective tax rate19.1%17.7%19.0%24.5%19.7%19.6%16.0%6.7%8.2%−0.2%44.6%4.0%−4.2%14.1%7.4%4.2%25.2%−12.8%−78.2%−231%
Net income$1.71B$2.01B$2.21B$1.42B$2.22B$2.33B$2.01B$2.50B$968.0M$4.96B$602.0M$1.55B$1.00B$1.10B$1.28B−$2.43B$2.66B−$649.0M−$957.0M−$723.0M
Net margin15.2%16.3%17.6%11.1%16.0%16.7%21.4%23.3%9.7%48.9%5.7%13.9%8.8%9.4%10.6%−24.2%25.6%−6.1%−8.5%−6.2%
EPS · diluted$2.61$3.16$3.59$2.39$3.88$4.18$3.66$4.56$1.76$9.01$1.08$2.83$1.93$2.13$2.53−$4.83$5.23−$1.27−$1.87−$1.40
Diluted weighted average shares654M637M614M594M573M556M549M547M549M551M555M546M519M517M508M504M508M510M513M517M
Basic weighted average shares644M625M607M590M569M551M543M542M545M546M543M534M509M509M502M504M506M510M513M515M
EBITDA—$3.24B$3.49B$2.69B$3.57B$3.66B$1.13B$1.45B$1.21B$1.54B$2.04B$2.35B$2.56B$2.44B$2.22B−$1.77B$1.69B$1.01B$673.0M$734.0M
EBITDA margin—26.2%27.8%20.9%25.7%26.3%12.0%13.5%12.1%15.2%19.3%21.2%22.5%20.9%18.3%−17.6%16.3%9.5%6.0%6.3%
Depreciation & amortization$581.0M$631.0M$638.0M$685.0M$670.0M$712.0M$635.0M$792.0M$759.0M$800.0M$750.0M$771.0M$789.0M$823.0M$867.0M$1.07B$984.0M$997.0M$981.0M$955.0M
Stock-based compensation$136.0M$146.0M$140.0M$120.0M$119.0M$130.0M$122.0M$126.0M$126.0M$115.0M$107.0M$115.0M$122.0M$130.0M$146.0M$140.0M$115.0M$114.0M$117.0M$110.0M
Dividends per share$0.72$0.91$1.07$1.18$1.26$1.57$1.92$2.05$1.27$0.51$0.61$0.73$0.85$0.95$1.08$1.15$1.16$1.04$0.52$0.04

Quarterly

Baxter International income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$2.73B$2.49B$2.69B$2.70B$2.75B$2.63B$2.81B$2.83B$2.97B$2.70B$2.96B$2.98B
Net interest income−$73.00M−$78.00M−$86.00M−$87.00M−$90.00M−$64.00M−$58.00M−$58.00M−$58.00M−$66.00M−$64.00M−$61.00M
Cost of revenue$1.63B$1.53B$1.66B$1.67B$1.79B$1.76B$1.82B$1.89B$2.40B$1.81B$1.93B$1.98B
Gross profit$1.10B$961.0M$1.03B$1.03B$959.0M$861.0M$991.0M$950.0M$577.0M$891.0M$1.03B$994.0M
Gross margin40.3%38.6%38.3%38.3%34.8%32.8%35.3%33.5%19.4%33.0%34.9%33.4%
Research and development$276.0M$120.0M$130.0M$129.0M$211.0M$140.0M$134.0M$118.0M$126.0M$139.0M$129.0M$125.0M
Selling, general and administrative$683.0M$729.0M$723.0M$754.0M$761.0M$703.0M$718.0M$708.0M$761.0M$728.0M$735.0M$730.0M
Operating expenses—$846.0M$852.0M$878.0M————————
Operating income$304.0M$115.0M$179.0M$155.0M−$435.0M$58.00M$191.0M$172.0M−$729.0M$66.00M$217.0M$225.0M
Operating margin11.1%4.6%6.6%5.7%−15.8%2.2%6.8%6.1%−24.5%2.4%7.3%7.6%
Interest expense$117.0M$103.0M$104.0M——————$12.00M$13.00M$13.00M
Income before tax$221.0M$46.00M$117.0M$69.00M−$521.0M−$3.00M$133.0M$121.0M−$756.0M−$6.00M$158.0M$417.0M
Income tax expense$2.00M$40.00M$22.00M$8.00M−$33.00M−$67.00M$11.00M$172.0M$279.0M$11.00M$23.00M$119.0M
Effective tax rate0.9%87.0%18.8%11.6%6.3%2233%8.3%142%−36.9%−183%14.6%28.5%
Net income$245.0M$37.00M−$314.0M$140.0M−$512.0M$126.0M$91.00M−$46.00M−$1.13B−$15.00M$126.0M$294.0M
Net margin9.0%1.5%−11.7%5.2%−18.6%4.8%3.2%−1.6%−37.9%−0.6%4.3%9.9%
EPS · diluted$0.48$0.07−$0.61$0.27−$1.00$0.25$0.18−$0.09−$2.20−$0.03$0.24$0.57
Diluted weighted average shares506M510M511M512M513M514M514M514M513M515M518M520M
Basic weighted average shares506M508M510M510M513M512M513M514M513M515M517M517M
EBITDA$568.0M$386.0M$406.0M$409.0M−$190.0M$305.0M$448.0M$409.0M−$489.0M$303.0M$456.0M$464.0M
EBITDA margin20.8%15.5%15.1%15.2%−6.9%11.6%15.9%14.4%−16.4%11.2%15.4%15.6%
Depreciation & amortization$264.0M$271.0M$227.0M$254.0M$245.0M$247.0M$257.0M$237.0M$240.0M$237.0M$239.0M$239.0M
Stock-based compensation$43.00M$17.00M$20.00M$38.00M$39.00M$10.00M$35.00M$35.00M$37.00M$10.00M$33.00M$30.00M
Dividends per share$0.29$0.29$0.29$0.29$0.17$0.17$0.17$0.17$0.01$0.01$0.01$0.01

The main figures as JSON and plain text. See data and methodology.

BAX in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.